Amgen Investor Defends Decade-Old Derivative Suit
An Amgen Inc. shareholder told a California federal court Wednesday that she didn't need to make a demand for litigation before bringing her now-reopened, 9-year-old action against the company's officers and...To view the full article, register now.
Already a subscriber? Click here to view full article